Calliditas Therapeutics launches US IPO roadshow and targets a capital raise of MUSD 75

Calliditas Therapeutics AB (publ) will today launch an investor roadshow for a contemplated initial public offering of American Depositary Shares in the United States for trading on The Nasdaq Global Market in the United States and a concurrent private placement of common shares to certain qualified investors in Europe and other countries outside of the United States. The target size of the global offering is MUSD 75 of gross proceeds plus a potential over-allotment of 15 percent. The offering is subject to market conditions and investor demand and the number of American Depositary Shares and common shares that may be offered and the price for such instruments have not yet been determined.

Read more

By Optimum

For more information about Optimum Strategic Communications, please get in touch

We'd love to hear from you...

GET IN TOUCH